Logo - P&S Intelligence
  • Home
  • Report Store
    • Report Store
      • Consumer Products
      • Life Sciences
      • ICT and Media
      • Semiconductor and Electronics
      • Chemicals and Materials
      • Automotive and Transportation
      • Power and Energy
      • Heating & Cooling
      • Aerospace & Defense
      • Construction & Heavy Machinery
    • Back
  • Services
  • Knowledge Center
    • Knowledge Center
      • Press Journals
      • Blogs
      • Case Studies
    • Back
  • About Us
  • Contact Us
Peptide Therapeutics Market

Available Format: PDF

  • Get Free Sample
  • Make an Inquiry
  • Home
  • Life Sciences
  • Peptide Therapeutics Market

Peptide Therapeutics Market: Size, Share, Strategic Developments, and Growth Potential Estimation, 2023–2030

  • Published: August 2023
  • Report Code: 10348
  • Available Format: PDF
  • Report Description
  • Table of Contents
  • Request Free Sample

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Route of Administration

1.3.2. Market Segmentation by Application

1.3.3. Market Segmentation by Marketing Type

1.3.4. Market Segmentation by Geography

1.3.5. Analysis Period

1.3.6. Market Data Reporting Unit

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents

2.2.1.1. By region

2.2.1.2. By industry participants

2.2.1.3. By company type

2.3. Market Size Estimation

2.4. Market Breakdown and Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Market Segmentation

4.1.1. Overview by Route of Administration

4.1.1.1. Oral Route

4.1.1.2. Parenteral route

4.1.2. Overview by Application

4.1.2.1. Cancer

4.1.2.2. Central nervous system

4.1.2.3. Respiratory disorders

4.1.2.4. Metabolic disorders

4.1.2.5. Cardiovascular

4.1.2.6. Infection

4.1.2.7. Hematological disorders

4.1.2.8. Gastrointestinal disorders

4.1.2.9. Acromegaly

4.1.2.10. Others

4.1.3. Overview by Marketing Type

4.1.3.1. Branded peptide therapeutics

4.1.3.2. Generic peptide therapeutics

4.2. Market Dynamics

4.2.1. Trends

4.2.2. Drivers

4.2.2.1. Impact analysis of drivers on market forecast

4.2.3. Restraints

4.2.3.1. Impact analysis of restraints on market forecast

4.2.4. Opportunities

4.3. Porter’s Five Forces Analysis

Chapter 5. Market Size and Forecast by Route of Administration

5.1. Oral Route

5.2. Parenteral Route

Chapter 6. Market Size and Forecast by Application

6.1. Cancer

6.2. Central Nervous System

6.3. Respiratory Disorders

6.4. Metabolic Disorders

6.5. Cardiovascular

6.6. Infection

6.7. Hematological Disorders

6.8. Gastrointestinal Disorders

6.9. Acromegaly

6.10. Others

Chapter 7. Market Size and Forecast by Marketing Type

7.1. Branded Peptide Therapeutics

7.2. Generic Peptide Therapeutics

Chapter 8. Market Size and Forecast by Geography

8.1. North America Peptide Therapeutics Market

8.1.1. By Route of Administration

8.1.2. By Application

8.1.3. By Marketing Type

8.1.4. By Country – The U.S and Canada

8.2. Europe Peptide Therapeutics Market

8.2.1. By Route of Administration

8.2.2. By Application

8.2.3. By Marketing Type

8.2.4. By Country –Germany, France, The U.K and rest of Europe

8.3. Asia-Pacific Peptide Therapeutics Market

8.3.1. By Route of Administration

8.3.2. By Application

8.3.3. By Marketing Type

8.3.4. By Country -China, Japan, India and Rest of Asia-Pacific

8.4. Latin America Peptide Therapeutics Market

8.4.1. By Route of Administration

8.4.2. By Application

8.4.3. By Marketing Type

8.4.4. By Country – Brazil, Mexico and Rest of Latin America

8.5. Middle East & Africa Peptide Therapeutics Market

8.5.1. By Route of Administration

8.5.2. By Application

8.5.3. By Marketing Type

Chapter 9. Competitive Landscape

9.1. Competitive Analysis of Key Players

9.2. Global Strategic Developments

Chapter 10. Company Profiles

10.1. Bachem Holding AG

10.1.1. Business Overview

10.1.2. Product and Service Offerings

10.1.3. Key Financial Summary

10.1.4. Strategic Growth Plan

10.2. Amgen, Inc.

10.2.1. Business Overview

10.2.2. Product and Service Offerings

10.2.3. Key Financial Summary

10.2.4. Strategic Growth Plan

10.3. AstraZeneca plc

10.3.1. Business Overview

10.3.2. Product and Service Offerings

10.3.3. Key Financial Summary

10.3.4. Strategic Growth Plan

10.4.  Merck & Co. Inc.

10.4.1. Business Overview

10.4.2. Product and Service Offerings

10.4.3. Key Financial Summary

10.4.4. Strategic Growth Plan

10.5.  Eli Lily and Company

10.5.1. Business Overview

10.5.2. Product and Service Offerings

10.5.3. Key Financial Summary

10.5.4. Strategic Growth Plan

10.6. CordenPharma International GmbH

10.6.1. Business Overview

10.6.2. Product and Service Offerings

10.6.3. Key Financial Summary

10.6.4. Strategic Growth Plan

10.7. Ipsen S.A.

10.7.1. Business Overview

10.7.2. Product and Service Offerings

10.7.3. Key Financial Summary

10.7.4. Strategic Growth Plan

10.8. Novartis AG

10.8.1. Business Overview

10.8.2. Product and Service Offerings

10.8.3. Key Financial Summary

10.8.4. Strategic Growth Plan

10.9.  PolyPeptide Group

10.9.1. Business Overview

10.9.2. Product and Service Offerings

10.9.3. Key Financial Summary

10.9.4. Strategic Growth Plan

10.10. F. Hoffmann-La Roche AG

10.10.1. Business Overview

10.10.2. Product and Service Offerings

10.10.3. Key Financial Summary

10.10.4. Strategic Growth Plan

10.11. Novo Nordisk A/S

10.11.1. Business Overview

10.11.2. Product and Service Offerings

10.11.3. Key Financial Summary

10.11.4. Strategic Growth Plan

10.12. Sanofi

10.12.1. Business Overview

10.12.2. Product and Service Offerings

10.12.3. Key Financial Summary

10.12.4. Strategic Growth Plan

10.13. Teva Pharmaceutical Industries Ltd.

10.13.1. Business Overview

10.13.2. Product and Service Offerings

10.13.3. Key Financial Summary

10.13.4. Strategic Growth Plan

*Note: Key financial summary and strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.

Chapter 11. Appendix

11.1. Abbreviations

Place An Order

USD 4900 USD 6400 USD 8400
  • INQUIRE BEFORE PURCHASE
Connect with our sales team
  • +91 93541 34657
  • [email protected]
Customized Report Solution

Get a bespoke market intelligence solution

  • Buy report sections that meet your requirements
  • Get the report customized as per your needs
  • Request Customized Report
Our Client Partners
Client
Share this report

Want a report tailored exactly to your business strategy?

Request Customization

Want an insight-rich discussion with the report author?

Speak to Analyst
 
We are committed to ensuring the highest level of client satisfaction
Quality Acknowledgement
Quality Acknowledgement

Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you

Unmatched Standards
Unmatched Standards

Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights

Reach Us
Reach Us Whenever You Need

With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required

Data Security
Complete Data Security

We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws

  • Make An Enquiry
  • Request Free Sample
Connect with us
Quick Links
  • Research Methodology
  • Career
  • Media Citations
  • FAQs
  • Events and Conferences
Find Help
  • How to Order
  • Privacy Policy
  • Terms & Conditions
  • Sitemap
24/7 Customer Support
  • India: +91 93541 34657
  • For business enquiries - [email protected]
  • For career enquiries - [email protected]
  • Dun-Verified
  • Paypal-Secure

©2026 P&S Intelligence. All Rights Reserved.

We use cookies to enhance your experience. By continuing to use this site you consent to our use of cookies. Privacy Policy